EIR Sovereign Pharmaceuticals Jan 2018

Patty Kaewussdangkul FDA$595.00 - Available Now

FDA investigators audited the Sovereign Pharmaceuticals - Fort Worth, TX, United States facility and issued inspectional observation (via FDA 483) on 12 Jan 2018.

Product details

  • Category:
  • Inspection end: 12 Jan 2018
  • Location: Fort Worth, United States
  • FEI: 3003229412
Add To Cart